Wayne Fenton
#94,947
Most Influential Person Now
American psychiatrist
Wayne Fenton's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Wayne Fenton Influential?
(Suggest an Edit or Addition)According to Wikipedia, Wayne Fenton was an American psychiatrist, well known for his academic contributions to the study of schizophrenia including key contributions to the classification of subtypes. In 2006 he was killed at his office in Bethesda, Maryland, by a 19-year-old patient.
Wayne Fenton's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. (2008) (1839)
- The NIMH-MATRICS consensus statement on negative symptoms. (2006) (1094)
- Determinants of medication compliance in schizophrenia: empirical and clinical findings. (1997) (967)
- Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria (2004) (867)
- The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. (2008) (590)
- A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. (2005) (436)
- How should DSM-V criteria for schizophrenia include cognitive impairment? (2007) (374)
- Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia (2004) (369)
- Natural history of schizophrenia subtypes. II. Positive and negative symptoms and long-term course. (1991) (348)
- Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia (2000) (332)
- Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. (1997) (323)
- A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia. (2001) (306)
- The positive-negative distinction in schizophrenia. Review of natural history validators. (1992) (282)
- Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. (1994) (273)
- What Are the Right Targets for Psychopharmacology? (2003) (245)
- Assessment of community functioning in people with schizophrenia and other severe mental illnesses: a white paper based on an NIMH-sponsored workshop. (2007) (220)
- Changing middle schoolers' attitudes about mental illness through education. (2004) (215)
- Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. (2008) (202)
- Depression, suicide, and suicide prevention in schizophrenia. (2000) (188)
- Natural history of schizophrenia subtypes. I. Longitudinal study of paranoid, hebephrenic, and undifferentiated schizophrenia. (1991) (159)
- The prognostic significance of obsessive-compulsive symptoms in schizophrenia. (1986) (158)
- Psychiatric epidemiology: it's not just about counting anymore. (2005) (152)
- Subtype progression and pathophysiologic deterioration in early schizophrenia. (1993) (151)
- Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia. (2002) (147)
- Delayed detection of psychosis: causes, consequences, and effect on public health. (2000) (146)
- Treatment of schizophrenia 1999 (1999) (136)
- Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder (2003) (135)
- Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status (2004) (134)
- Prevalence of spontaneous dyskinesia in schizophrenia. (2000) (133)
- Mood disorders: cardiovascular and diabetes comorbidity (2006) (121)
- Risk factors for spontaneous dyskinesia in schizophrenia. (1994) (120)
- Medicine. What are the right targets for psychopharmacology? (2003) (115)
- Testing systems for assessment of negative symptoms in schizophrenia. (1992) (96)
- Diagnosis of schizophrenia: a critical review of current diagnostic systems. (1981) (88)
- Randomized trial of general hospital and residential alternative care for patients with severe and persistent mental illness. (1998) (88)
- Risk of schizophrenia in character disordered patients. (1989) (87)
- Evolving perspectives on individual psychotherapy for schizophrenia. (2000) (85)
- Classical subtypes for schizophrenia: literature review for DSM-IV. (1991) (83)
- Sustained remission in drug-free schizophrenic patients. (1987) (81)
- Testing systems for assessment of negative symptoms in schizophrenia (1991) (67)
- Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients (1997) (60)
- Evidence-based psychosocial treatment for schizophrenia. (2000) (59)
- Cost and cost-effectiveness of hospital vs residential crisis care for patients who have serious mental illness. (2002) (59)
- Informed Consent in Early Psychosis Research: National Institute of Mental Health workshop, November 15, 2000. (2001) (56)
- Schizophrenia, IX: Cognition in schizophrenia--the MATRICS initiative. (2004) (53)
- A national study of psychiatrists' professional activities. (1992) (47)
- Suicide rate in schizophrenia in the Northern Finland 1966 Birth Cohort (2009) (47)
- Prognostic scale for chronic schizophrenia. (1987) (47)
- Drs. Fenton and McGlashan Reply (1986) (46)
- Recovery from schizophrenic psychoses within the northern Finland 1966 Birth Cohort. (2005) (43)
- Course and outcome in schizophrenia (1997) (39)
- Medication-Induced Weight Gain and Dyslipidemia in Patients With Schizophrenia (2006) (38)
- Comorbid conditions in schizophrenia (2001) (37)
- Line drawing as a possible measure of lateralized motor performance in schizophrenia (1997) (35)
- Shared decision making: a model for the physician–patient relationship in the 21st century? (2003) (35)
- Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective (2003) (35)
- Depression and comorbid medical illness: the National Institute of Mental Health perspective (2003) (34)
- A comparison of DSM-III and DSM-III-R schizophrenia. (1988) (33)
- Psychiatry Residency Training, the Physician-Scientist, and the Future of Psychiatry (2004) (30)
- Male and female psychiatrists and their patients. (1987) (24)
- Beginning careers in academic psychiatry for women--"Bermuda Triangle"? (1993) (24)
- How Do Children Stigmatize People With Mental Illness (2007) (23)
- We can talk: individual psychotherapy for schizophrenia. (1997) (23)
- Medication-induced weight gain and dyslipidemia in patients with schizophrenia. (2008) (20)
- Trends in psychiatric practice, 1965-1980. (1984) (18)
- Can clozapine response be predicted? A naturalistic pilot study. (1993) (14)
- Psychosocial treatment of negative symptoms in schizophrenia. (1990) (12)
- Long-term outcome of obsessive-compulsive disorder with psychotic features. (1990) (11)
- Editors' Introduction: Building Mental Illness Stigma Research (2004) (10)
- Long-Term Residential Care: Treatment of Choice for Refractory Character Disorder? (1990) (9)
- Heterogeneity, Subtypes, and Longitudinal Course in Schizophrenia (2000) (8)
- Training and career activity. The experience of the Yale Advanced Track Program. (1990) (8)
- Definitions of schizophrenia. (1982) (7)
- Risk factors for spontaneous dyskinesia (1993) (6)
- A programmatic approach to socially complex intervention development. (2000) (6)
- Clinical challenges in the psychopharmacology of schizophrenia. (1997) (5)
- Diagnostic Efficiency of DSM-III Schizophrenia (1989) (5)
- Sexual abuse and psychopathology. (1993) (5)
- 581 Satisfaction with treatment outcome and noncompliance in schizophrenia (1997) (5)
- Symptoms in Schizophrenia (1986) (4)
- DSM-IV Training Guide; DSM-IV Guidebook; DSM-IV Handbook of Differential Diagnosis; Diagnostic and Statistical Manual of Mental Disorders, 4th ed.: Primary Care Version (1996) (4)
- Spontaneous dyskinesia in schizophrenia (1995) (3)
- Translational Research: Pathway to Improved Practice? (2002) (3)
- Residential alternatives to hospitalization for patients with severe and persistent mental illness: Should patients with comorbid substance abuse be excluded? (2006) (3)
- Clinical Challenges in the Psychopharmacology of Schizophrenia: Editors' Introduction (1997) (3)
- 524. Randomized trial of supplemental EPA for residual symptoms of schizophrenia (2000) (3)
- Dr. Fenton and Colleagues Reply (2003) (3)
- The Psychotherapy of Schizophrenia: Effective Clinical Approaches—Controversies, Critiques and Recommendations (1995) (2)
- Handbook of borderline disorders (1993) (2)
- Review: most antipsychotic drugs are associated with weight gain (2000) (2)
- Psychosocial Treatment: More Than Compassion and Common Sense? (2000) (2)
- Expressed emotion in psychiatric hospital staff (1993) (2)
- 768 The prevalence of spontaneous dyskinesia in never-medicated patients with schizophrenia and other psychiatric disorders (1997) (2)
- The Psychiatric Team and the Social Definition of Schizophrenia: An Anthropological Study of Person and Illness (1998) (2)
- Frieda Fromm-Reichmann, 1889–1957 (1998) (2)
- Medication-Psychotherapy Combination Most Effective for Schizophrenia (1998) (1)
- Residential alternatives to hospitalization for patients with severe and persistent mental illness: Should patients with comorbid substance abuse be excluded? (2006) (1)
- Editor's concluding remarks: psychosocial treatment: more than compassion and common sense? (2000) (1)
- Placebo response in a double-blind therapeutic supplementation trial in stabilized outpatients with schizophrenia (2003) (1)
- Community Mental Health: Principles and Practice (1990) (0)
- Risk of schizophrenia in character disorders (1989) (0)
- Mental Health in Our Future Cities: Maudsley Monograph 42 (2001) (0)
- Natural history of the deficit syndrome (1993) (0)
- Mentally ill adults had fewer homeless days in staffed group homes than in independent flats (2000) (0)
- Serious Mental Illness and the Family: The Practitioner’s Guide (1999) (0)
- By Force of Fantasy: How We Make Our Lives (1998) (0)
- pproaching a Consensus Cognitive Battery for linical Trials in Schizophrenia : The NIMH-MATRICS onference to Select Cognitive Domains and Test riteria (2004) (0)
- 30 Suicide risk factors in schizophrenia (1997) (0)
- S-69-2 Spontaneous dyskinesia and psychopathology in the pre-neuroleptic era (1996) (0)
- Evaluating an alternative to hospitalization for patients with severe and persistent mental illness (1995) (0)
- Comments on the Klerman-Stone Debate on Osheroff v. Chestnut Lodge (1991) (0)
- Dr. Fenton and Associates Reply (2006) (0)
- 71-3 Longitudinal perspectives on the deficit syndrome (1997) (0)
- Chestnut lodge prognostic scale: Validation in Maine (1993) (0)
- Ensuring public trust (2004) (0)
This paper list is powered by the following services:
Other Resources About Wayne Fenton
What Schools Are Affiliated With Wayne Fenton?
Wayne Fenton is affiliated with the following schools:
